Collectively, these results suggest the noncanonical NFκB pathway is activated early in RVFV MP12 infection and even before the canonical NFκB pathway, implying the noncanonical pathway, and specifically p100 processing, may be co-opted by RVFV as a means to subvert the antiviral IFN response. The gene discussed is IFNA1; the disease is infection.